178 related articles for article (PubMed ID: 21292754)
1. The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer.
Jonnalagadda S; Smith C; Mhango G; Wisnivesky JP
Chest; 2011 Aug; 140(2):433-440. PubMed ID: 21292754
[TBL] [Abstract][Full Text] [Related]
2. Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer.
Jonnalagadda S; Arcinega J; Smith C; Wisnivesky JP
Cancer; 2011 Oct; 117(20):4724-31. PubMed ID: 21452193
[TBL] [Abstract][Full Text] [Related]
3. Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer.
Wisnivesky JP; Arciniega J; Mhango G; Mandeli J; Halm EA
Thorax; 2011 Apr; 66(4):287-93. PubMed ID: 21131298
[TBL] [Abstract][Full Text] [Related]
4. Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA-IIA non-small cell lung cancer, a retrospective cohort study.
Zhai W; Duan F; Zheng Y; Yan Q; Dai S; Chen T; Chen J; Wang J
World J Surg Oncol; 2020 Sep; 18(1):258. PubMed ID: 32998771
[TBL] [Abstract][Full Text] [Related]
5. Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer.
Nwogu CE; Groman A; Fahey D; Yendamuri S; Dexter E; Demmy TL; Miller A; Reid M
Ann Thorac Surg; 2012 May; 93(5):1614-9; discussion 1619-20. PubMed ID: 22440365
[TBL] [Abstract][Full Text] [Related]
6. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.
Ludwig MS; Goodman M; Miller DL; Johnstone PA
Chest; 2005 Sep; 128(3):1545-50. PubMed ID: 16162756
[TBL] [Abstract][Full Text] [Related]
7. Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer.
Deng W; Xu T; Wang Y; Xu Y; Yang P; Gomez D; Liao Z
Lung Cancer; 2018 Aug; 122():60-66. PubMed ID: 30032846
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the extent of lymph node involvement in stage II-N1 non-small cell lung cancer.
Li ZM; Ding ZP; Luo QQ; Wu CX; Liao ML; Zhen Y; Chen ZW; Lu S
Chest; 2013 Oct; 144(4):1253-1260. PubMed ID: 23744276
[TBL] [Abstract][Full Text] [Related]
9. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
[TBL] [Abstract][Full Text] [Related]
10. New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non-small cell lung cancer.
Zhang J; Liu L; Wang G; Huang C; Chen Y; Zhang Y; Guo C; Li S
Thorac Cancer; 2019 Dec; 10(12):2253-2258. PubMed ID: 31617316
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
Park S; Cho S; Yum SW; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
[TBL] [Abstract][Full Text] [Related]
13. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
14. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
Urban D; Bar J; Solomon B; Ball D
J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLC.
Katsumata S; Aokage K; Ishii G; Nakasone S; Sakai T; Okada S; Miyoshi T; Tane K; Tsuboi M
J Thorac Oncol; 2019 Aug; 14(8):1408-1418. PubMed ID: 31055075
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of lymph nodes count on survival of patients with distal cholangiocarcinomas.
Lin HP; Li SW; Liu Y; Zhou SJ
World J Gastroenterol; 2018 Mar; 24(9):1022-1034. PubMed ID: 29531466
[TBL] [Abstract][Full Text] [Related]
18. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
Osarogiagbon RU; Yu X
J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
[TBL] [Abstract][Full Text] [Related]
19. Effects of Postoperative Radiotherapy on Survival of Patients With Stage IIIA Resected Non-Small Cell Lung Cancer: Analysis of the SEER Database.
Gao F; Li N; Xu Y; Yang G
J Natl Compr Canc Netw; 2020 Jun; 18(6):718-727. PubMed ID: 32502986
[TBL] [Abstract][Full Text] [Related]
20. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
